BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.41% |
| 2 | Financials | 6.99% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 5.09% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Saic
SAIC
$5.33B
| $1.15M | ﹤0.01% |
13,199
+5,133
| +64% | +$436K |
|
1677
PUT
Public Storage
PSA
$60.8B
| $1.15M | ﹤0.01% |
47
| – | – |
|
1678
RLJ Lodging Trust
RLJ
$1.7B
| $1.15M | ﹤0.01% |
67,654
+40,078
| +145% | +$681K |
|
|
ACHN
1679
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.14M | ﹤0.01% |
317,676
+299,615
| +1,659% | +$1.16M |
|
1680
PUT
Emerson Electric
EMR
$91.4B
| $1.14M | ﹤0.01% |
171
| – | – |
|
1681
CALL
United States Natural Gas Fund
UNG
$494M
| $1.14M | ﹤0.01% |
143
-318
| -69% | -$25.6K |
|
1682
DigitalBridge
DBRG
$2.95B
| $1.14M | ﹤0.01% |
47,306
+42,609
| +907% | +$882K |
|
1683
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$140M
| $1.14M | ﹤0.01% |
749
+117
| +19% | +$186K |
|
1684
PUT
Yum China
YUMC
$16.2B
| $1.14M | ﹤0.01% |
250
| – | – |
|
1685
EQT Corp
EQT
$34.4B
| $1.13M | ﹤0.01% |
106,059
+71,178
| +204% | +$917K |
|
1686
PUT
Illinois Tool Works
ITW
$82.5B
| $1.13M | ﹤0.01% |
72
-610
| -89% | -$92.6K |
|
|
VMW
1687
CALL
DELISTED
VMware, Inc
VMW
| $1.13M | ﹤0.01% |
75
| – | – |
|
1688
PUT
NetApp
NTAP
$40B
| $1.12M | ﹤0.01% |
214
| – | – |
|
1689
NCR Voyix
VYX
$1.14B
| $1.12M | ﹤0.01% |
58,033
+33,425
| +136% | +$646K |
|
1690
PUT
Wayfair
W
$14.1B
| $1.12M | ﹤0.01% |
+100
| New | +$12.8K |
|
|
ABMD
1691
DELISTED
Abiomed Inc
ABMD
| $1.12M | ﹤0.01% |
6,272
-24,693
| -80% | -$5.34M |
|
|
EGRX
1692
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.11M | ﹤0.01% |
19,616
+431
| +2% | +$24.2K |
|
1693
CALL
Altria Group
MO
$109B
| $1.1M | ﹤0.01% |
270
| – | – |
|
1694
CALL
Teva Pharmaceuticals
TEVA
$42.3B
| $1.1M | ﹤0.01% |
1,600
| – | – |
|
1695
Sonoco
SON
$5.73B
| $1.1M | ﹤0.01% |
18,880
+4,533
| +32% | +$270K |
|
|
PACW
1696
DELISTED
PacWest Bancorp
PACW
| $1.1M | ﹤0.01% |
30,176
+25,521
| +548% | +$922K |
|
|
AYX
1697
DELISTED
Alteryx Inc
AYX
| $1.09M | ﹤0.01% |
10,104
+1,945
| +24% | +$241K |
|
1698
Semtech
SMTC
$13B
| $1.09M | ﹤0.01% |
22,330
+14,278
| +177% | +$678K |
|
|
WMGI
1699
DELISTED
Wright Medical Group Inc
WMGI
| $1.09M | ﹤0.01% |
52,596
+33,837
| +180% | +$805K |
|
1700
Manhattan Associates
MANH
$11.5B
| $1.08M | ﹤0.01% |
13,412
+9,469
| +240% | +$759K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.